Informa Pharma Intelligence Plans 24-Hour Webinar Series
Informa Pharma Intelligence is set to host a free, 24-hour interactive webinar series on the latest insights into COVID-19. The [...]
Blog Post Explores Novel Value Elements for Assessment of COVID-19 Drugs
A recent Health Affairs blog post suggests the inclusion of more novel value elements in the assessment of COVID-19 drugs [...]
ISPOR-FDA Summit Transitions to Virtual Event
The International Society for Pharmacoeconomics and Outcomes Research's (ISPOR) announced that the joint ISPOR-FDA Summit 2020, set for Sept. 29, [...]
Cytel Offers On-Demand Access to Webinar on Synethic, External Control Arms
A new on-demand webinar from Cytel offers insights into synthetic and external control arms in clinical trials. The webinar features [...]
Opinion: Move Forward with Evidence-based Care as Foundation
Evidence-based care should be the bedrock of health care moving forward, the authors of a recent opinion piece published on [...]
Cytel Paper Offers Insight into Trial Recruitment Targets
A new white paper from Cytel offers insight into how recruitment targets are "met with sound starting assumptions and key [...]
How Can HEOR Boost Outcomes?
The health economics and outcomes research (HEOR) framework can help facilitate more robust decision-making using "powerful data and insights," ISPOR [...]
Blog Post Touts VA, ICER Partnership as ‘Highly Beneficial’
The partnership between the Department of Veterans Affairs (VA) and the Institute for Clinical and Economic Review (ICER) has provided [...]
Kreis: Challenging Price of Costly CF Drug Not ‘Discrimination’
Maurice Kreis, head of the New Hampshire Office of the Consumer Advocate, says challenging the price of Vertex Pharmaceuticals' cystic [...]
Study Suggests Pfizer’s Vyndaqel is Too Expensive
A recent study published in JAMA Cardiology suggests the price tag on Pfizer's Vyndaqel is too high. According to a [...]
Sarepta Therapeutics’ Berry Talks Access to Rare Disease Treatments
Sarepta Therapeutics' Diane Berry in a recent Patients Rising Podcast discussed access to treatments for rare diseases. Berry is Sarepta [...]
ICER to Review Most Significant Drug Price Hikes
The Institute for Clinical and Economic Review (ICER) is set to review whether the most significant drug price increases are [...]
Study: Almost 9 in 10 Concerned about High Drug Prices Due to COVID-19
Almost nine in 10 adults in the U.S. are either "very" (55 percent) or "somewhat" (33 percent) concerned pharma will [...]
Updated Guide to HEOR/Market Access Writing Release
The 2020 update to "Evidence generation and communication: a guide to getting started in HEOR/market access medical writing" has been [...]
ISPOR Offering Short Courses on Value Assessment Frameworks, HTA
The International Society of Pharmacoeconomics and Outcomes Research (ISPOR) is offering two short, online courses. Below are the two courses: [...]
Analysis Finds Clinical Trial Costs are Actually Modest
A new analysis published in BMJ Open suggests that clinical trial costs for new drugs are generally modest, according to [...]
Study: ICER Reports Play Major Role in MCOs’ Decisions
Many managed care organizations say they use reports by the Institute for Clinical and Economic Review (ICER) in their decision-making, [...]
Joint Project Establishes RWD Link
ONC reported that the Coordinated Registry Network for Women's Health Technologies, a joint project involving ONC, the FDA and NIH, [...]
Report Highlights Growing Role of AI in Healthcare
A recent report by Alteryx offers a deeper look into new research from HIMSS Media which reveals new insights into [...]
ICON’s Row, Capobianco and Adamski Talk Increasing Participation in Real-World Studies
In a recent interview with PMLiVE, ICON plc's Bill Row, Bruce Capobianco and Maggie Adamski discussed ways to increase patient [...]
NIH Expands Precision Medicine Program to Improve Understanding of COVID-19
The National Institute of Health's All of Us precision medicine program announced an expanded initiative aimed at generating insights into [...]
Fauci, Smith to Deliver Keynote Addresses for Virtual GHC Summit
Anthony Fauci, National Institute of Allergy and Infectious Disease director, and Brad Smith, CMMI director, have been tapped to deliver [...]
Guidehouse’s Austin Talks Waste in Supply Chain
Guidehouse Health Systems Director Rob Austin in a new Relentless Health Value podcast discusses the financial waste produced by mismanaged [...]
Blog Post Urges Greater Understanding of Patient Experience Regarding De-implementation
A recent blog post on AcademyHealth says it is imperative to further study how patients deal with de-implementation. The authors, [...]
MAPS Offering Course on AI in Medical Affairs
The Medical Affairs Professional Society (MAPS) is offering a course on the foundations of artificial intelligence in medical affairs. Open [...]